Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
4
Halozyme Therapeutics
HALO
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
BAK Braskem
- 3.570
- -0.120-3.25%
Close Mar 10 16:00 ET
- 3.560
- -0.010-0.27%
Post 19:57 ET
1.42BMarket Cap-0.74P/E (TTM)
3.680High3.525Low475.82KVolume3.630Open3.690Pre Close1.71MTurnover0.47%Turnover RatioLossP/E (Static)398.48MShares10.98052wk High-1.74P/B361.93MFloat Cap3.41552wk Low--Dividend TTM101.38MShs Float26.039Historical High--Div YieldTTM4.20%Amplitude0.567Historical Low3.594Avg Price1Lot Size
Braskem Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.70%77.41B | 14.74%19.15B | 27.52%21.27B | 7.43%19.08B | -7.85%17.92B | -26.89%70.57B | -12.11%16.69B | -34.31%16.68B | -30.12%17.76B | -27.25%19.45B |
| Operating revenue | 9.70%77.41B | 14.74%19.15B | 27.52%21.27B | 7.43%19.08B | -7.85%17.92B | -26.89%70.57B | -12.11%16.69B | -34.31%16.68B | -30.12%17.76B | -27.25%19.45B |
| Cost of revenue | 5.72%71.41B | 14.81%18.01B | 18.06%19.02B | 2.24%17.69B | -9.49%16.71B | -20.68%67.55B | -17.75%15.68B | -30.45%16.11B | -18.91%17.3B | -14.54%18.46B |
| Gross profit | 98.51%6B | 13.79%1.15B | 295.25%2.25B | 202.83%1.39B | 22.94%1.21B | -73.40%3.02B | 1,392.31%1.01B | -74.47%569M | -88.75%459M | -80.80%985M |
| Operating expense | 24.86%7.16B | 46.41%3.57B | 6.34%1.22B | 19.38%1.16B | 3.06%1.21B | -19.00%5.74B | 55.42%2.44B | -25.11%1.15B | -21.39%970M | -4.77%1.18B |
| Selling and administrative expenses | 5.52%4.63B | 15.47%1.31B | 6.17%1.17B | -1.80%1.03B | 1.65%1.11B | -9.93%4.39B | -14.76%1.14B | -8.08%1.1B | -10.46%1.05B | -5.94%1.09B |
| -Selling and marketing expense | 3.91%1.99B | 5.71%555M | 26.79%530M | -9.70%447M | -3.77%459M | -9.11%1.92B | -2.05%525M | -18.83%418M | -2.94%495M | -12.96%477M |
| -General and administrative expense | 6.76%2.64B | 23.82%759M | -6.42%641M | 5.20%587M | 5.84%652M | -10.56%2.47B | -23.28%613M | 0.00%685M | -16.22%558M | 0.33%616M |
| Research and development costs | 20.89%463M | 23.28%143M | 18.48%109M | 30.86%106M | 12.77%106M | 2.41%383M | -2.52%116M | -11.54%92M | 3.85%81M | 28.77%94M |
| Other taxes | ---- | ---- | -26.92%-66M | 61.81%-55M | -14.29%-16M | ---- | ---- | ---52M | -414.29%-144M | -55.56%-14M |
| Other operating expenses | 114.29%2.07B | 102.88%1.97B | 25.00%10M | 465.00%73M | 160.00%13M | -47.41%966M | 654.26%973M | -96.57%8M | -350.00%-20M | -54.55%5M |
| Operating profit | 57.07%-1.17B | -69.42%-2.42B | 276.12%1.03B | 145.40%232M | 98.45%-3M | -163.53%-2.72B | 13.18%-1.43B | -184.10%-582M | -117.96%-511M | -104.96%-193M |
| Net non-operating interest income expense | -31.27%-5.13B | -54.97%-1.7B | -16.92%-1.15B | -54.24%-1.33B | 1.24%-959M | -5.93%-3.91B | -14.63%-1.1B | -39.74%-981M | 13.21%-861M | 2.90%-971M |
| Non-operating interest income | -17.37%1.26B | -62.33%197M | 3.98%366M | -0.60%330M | 15.97%363M | 42.59%1.52B | 76.09%523M | -39.83%352M | 23.42%332M | 137.12%313M |
| Non-operating interest expense | 13.65%5.44B | 6.38%2.1B | 17.11%1.1B | 34.32%1.17B | 6.74%1.06B | 14.59%4.78B | 137.67%1.98B | -26.88%941M | 7.37%874M | 54.59%994M |
| Total other finance cost | 47.30%953M | 42.54%-204M | 4.85%411M | 51.72%484M | -10.00%261M | 10.98%647M | -183.92%-355M | --392M | -28.64%319M | -40.70%290M |
| Other net income (expense) | -2,728.28%-11.43B | -702.29%-4.21B | 18.87%-1.19B | -4,502.80%-4.93B | -184.64%-1.11B | 181.16%435M | 85.41%699M | -47.83%-1.47B | 97.02%-107M | -38.40%1.31B |
| Gain on sale of security | -2,354.40%-11.52B | -1,676.33%-4.73B | 17.06%-1.19B | -543.74%-4.54B | -273.02%-1.07B | 195.87%511M | -47.64%300M | -44.01%-1.43B | 142.58%1.02B | -72.46%619M |
| Earnings from equity interest | -400.00%-21M | -100.00%-2M | 400.00%9M | -1,000.00%-22M | -138.46%-5M | -80.00%7M | -111.11%-1M | ---3M | -120.00%-2M | -23.53%13M |
| Special income (charges) | 230.12%108M | -25.76%948M | -401.09%-461M | 74.82%-279M | 37.50%-100M | -118.42%-83M | 1,230.09%1.28B | ---92M | 7.82%-1.11B | -25.00%-160M |
| -Less：Restructuring and merger&acquisition | ---- | ---- | 900.00%20M | --0 | --0 | ---- | ---- | --2M | -57.14%3M | --4M |
| -Less:Other special charges | ---- | ---- | 377.45%487M | -64.67%378M | -60.14%57M | ---- | ---- | --102M | -9.48%1.07B | 20.17%143M |
| -Write off | -230.12%-108M | -112.77%-6M | -283.33%-46M | -382.86%-99M | 230.77%43M | 118.42%83M | 176.47%47M | ---12M | 169.23%35M | 44.44%13M |
| Other non- operating income (expenses) | ---- | ---- | 684.21%447M | -368.42%-89M | -91.88%68M | ---- | ---- | --57M | -2,000.00%-19M | 7,075.00%837M |
| Income before tax | -186.39%-17.73B | -356.13%-8.33B | 56.70%-1.31B | -306.82%-6.02B | -1,538.19%-2.07B | -13,274.47%-6.19B | 18.01%-1.83B | -201.49%-3.03B | 14.84%-1.48B | -97.13%144M |
| Income tax | -336.33%-5.68B | -3,156.00%-2.44B | 5.93%-444M | -222.26%-2.11B | -594.90%-681M | -250.00%-1.3B | 78.20%-75M | -213.46%-472M | -138.55%-656M | -109.16%-98M |
| Net income | -146.46%-12.05B | -236.21%-5.89B | 66.07%-868M | -374.61%-3.91B | -674.38%-1.39B | -495.62%-4.89B | 7.01%-1.75B | -79.89%-2.56B | 43.75%-823M | -93.87%242M |
| Net income continuous Operations | -146.46%-12.05B | -236.21%-5.89B | 66.07%-868M | -374.15%-3.91B | -674.38%-1.39B | -495.62%-4.89B | 7.01%-1.75B | -79.89%-2.56B | 43.68%-824M | -93.87%242M |
| Net income discontinuous operations | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Minority interest income | -135.37%-732M | -36.36%-240M | -97.86%-277M | -222.64%-171M | -177.59%-45M | 35.88%-311M | -1.73%-176M | 56.11%-140M | 7.02%-53M | -9.38%58M |
| Net income attributable to the parent company | -147.22%-11.32B | -258.48%-5.65B | 75.48%-593M | -384.57%-3.74B | -830.98%-1.35B | -1,262.80%-4.58B | 7.89%-1.58B | -119.22%-2.42B | 45.16%-771M | -95.26%184M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -147.22%-11.32B | -258.48%-5.65B | 75.48%-593M | -384.57%-3.74B | -830.98%-1.35B | -1,262.80%-4.58B | 7.89%-1.58B | -119.22%-2.42B | 45.16%-771M | -95.26%184M |
| Basic earnings per share | -147.13%-28.3996 | -258.48%-14.1687 | 75.48%-1.4881 | -384.57%-9.3755 | -830.37%-3.3753 | -1,263.18%-11.4916 | 7.97%-3.9525 | -119.04%-6.068 | 45.21%-1.9348 | -95.26%0.4621 |
| Diluted earnings per share | -147.13%-28.3996 | -258.48%-14.1687 | 75.48%-1.4881 | -384.57%-9.3755 | -830.37%-3.3753 | -1,263.18%-11.4916 | 7.97%-3.9525 | -119.04%-6.068 | 45.21%-1.9348 | -95.26%0.4621 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call